Beschreibung

Senior International Product Manager with 10+ years of experience in IVD, HealthTech and B2B product strategy.

I help companies turn complex ideas into clear product strategies, AI-powered SaaS concepts, MVPs and operational automations using tools such as Make, n8n and generative AI.

My strength is combining strategic product thinking, scientific/technical understanding and hands-on execution. I can support you from market analysis, positioning and roadmap definition to workflow automation, AI use-case design, sales enablement and go-to-market preparation.

I am particularly comfortable with complex B2B environments, regulated industries, HealthTech, MedTech and SaaS projects where clarity, structure and business impact matter.

Branchenexpertise

Sprachen

Französisch
Muttersprachlich oder zweisprachig
Englisch
Muttersprachlich oder zweisprachig

Arbeitsortpräferenzen

Vor Ort möglich

Montpellier (bis zu 50 km), Paris (bis zu 50 km), Lyon (bis zu 50 km), Bordeaux (bis zu 50 km), Nice (bis zu 50 km)

Horiba ABX
International Product Manager — Hemostasis
PHARMAZEUTISCHE INDUSTRIE
April 2026 - April 2026
Montpellier, France
› Global product management of the hemostasis (coagulation) product line — reagents and analyzers — for the IVD business unit.
› Onboarding into the IVD hemostasis ecosystem and competitive intelligence on the global coagulation market.
Product management Regulatory Compliance (MDR, IVDR, FDA, MHRA, Health Canada) Marketing Stratégie de positionnement Vulgarisation scientifique
Sebia
Global Product Manager — Multiple Myeloma & Miscellaneous
PHARMAZEUTISCHE INDUSTRIE
Januar 2022 - Februar 2026 (4 Jahre und 1 Monat)
Lisses, France
› Led global upstream and downstream product strategy for the ELISA Free Light Chain (FLC) assay, supporting positioning, evidence generation, launch readiness and competitive differentiation for the aid to diagnosis and monitoring of multiple myeloma and AL amyloidosis.

› Owned the Electrophoresis specialties portfolio — CDT on capillary electrophoresis (Carbohydrate Deficient Transferrin, chronic alcoholism marker), and A1AT, vWF Multimers, CSF Oligoclonal Bands on gel electrophoresis — driving product positioning, lifecycle decisions and clinical evidence strategy.

› Managed the Gel Electrophoresis Instrumentation line (ASSIST and HYDRASYS analyzers), coordinating roadmap priorities with R&D and aligning with regional commercial needs.

› Orchestrated cross-functional coordination across R&D, Regulatory Affairs, Clinical Affairs, Manufacturing, Supply Chain and regional marketing teams (EMEA, Americas, APAC) to execute global launch and lifecycle plans.
Product management Vulgarisation scientifique Marketing Stratégie d'entreprise Stratégie de positionnement
Bio-Rad Laboratories
International Product Manager — Infectious Diseases
PHARMAZEUTISCHE INDUSTRIE
Oktober 2015 - Dezember 2021 (6 Jahre und 2 Monate)
Garches, Frankreich
› Led upstream and downstream global marketing for the ELISA Infectious Diseases portfolio (SARS-CoV-2, Mycology, ToRCH, Lyme, EBV), defining product positioning, competitive differentiation and go-to-market strategy across all regions.

› Drove product launches and phase-outs across the global portfolio, with transverse coordination across QA, RA, R&D, Communication, Global Supply Chain and Manufacturing.

› Developed global sales enablement assets (brochures, flyers, motion designs) and delivered training programs to support regional commercial teams across infectious disease portfolios.

› Represented the portfolio at national and international scientific congresses (ECCMID, TIMM, AAA, RICAI), gathering market intelligence and strengthening KOL relationships.
Regulatory Compliance (MDR, IVDR, FDA, MHRA, Health Canada) Product management Data science Sciences de la vie Marketing de contenu